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BACKGROUND
HIV-1 exhibits a high genetic diversity. It is currently divided into 4 groups: M, N, O and P as
shown on figure 1[1]. Recombination is a crucial mechanism of HIV evolution, and HIV-M
recombinants now account for more than 20% of HIV-1 infections[2]. HIV-M and HIV-O co-
circulation in Cameroon led in few patients to dual infections and to subsequent generation
of MO recombinants (MOrecs). The first dual M+O infections were described in Benin in
1995[3] and 3 MOrecs were identified in Cameroon in 1999[4,5] and 2004[6]. Due to historical
links with Western Central Africa, sporadic cases of superinfection/dual infections[7,8] and MO
recombinant infection[9] were also described in France.
The aim of this study was to determine the circulation level of dual M+O
Infections and associated MO recombinant forms in the last decade in France.
METHODS
1. The presence of both M and O genomes were looked for HIV-M+O / HIV-MO 
screening in 141 HIV-O patient samples collected from 2004 to 2014 by the 
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RESULTS
The presence of both M and O genomes were detected in 10/141
(7%) HIV-O infected patients.
The analysis of these cases allowed us to identify different situations:
- 2 M+O dual infections in 2 patients (RBF140 in 2004 and RBF216 in
2009),
- 3 MO recombinants associated :
- with the HIV-O parental strain in 2 epidemiologically linked
patients (BCF174, 2005 and BCF212, 2006)
- with both the M and O parental strains in 1 patient (RBF235,
2007)
- 6 MO recombinants without parental strains :
- RBF208 (2008), RBF221 (2 recombinants in the same patient,
2010), RBF222, (2010), RBF237 (2013), BCF204 (2013)
For each of these MO recombinants, whole genome or partial
sequences were analyzed. All the MO recombinant genetic patterns
were different with breakpoints in LTR (1 in 8), p17GAG (1 in 8), RT (3 in
8), INT (2 in 8), gp41 (1 in 8) and/or accessory genes (9 in 8) as shown
in the figures 2 and 3.
The 2 viruses found in the same patient RBF221 exhibited multiple
breakpoints in the accessory genes (at least 2 and 5 respectively).
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Figure 2. Genomic patterns of HIV MO recombinants detected in France 
Figure 3. Breakpoints found in vivo in MOrecs in France (blue
arrows) and in previous publications (orange arrows)
Conclusions
Although all described in Cameroonian native patients, we show 11
HIV-M+O dual infections and/or HIV-MO recombinant infections in
the past decade in France, highlighting these phenomenons are not
so rare. Moreover, the presence of MO recombinants circulating
without the presence of parental O or M strains, and in
epidemiologically linked patients demonstrate they are fit enough to
be transmitted and spread. Finally, as HIV-O are naturally resistant to
NNRTIs, the transmission of dual HIV-M+O infections or MO
recombinants carrying HIV-O genomic fragments underline the
importance of searching for these forms, evaluating their spread
dynamics and following the possible emergence of a CRF_MO.
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Figure 1. Genetic diversity of HIV-11
